Summary of Clinical Trials of Inactivated Influenza Vaccine—1978

John R. La Montagne, Gary R. Noble, Gerald V. Quinnan, George T. Curlin, William C. Blackwelder, Jacqueline I. Smith, Francis A. Ennis, and F. Marilyn Bozeman From the Development and Applications Branch, Microbiology and Infectious Diseases Program, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; the Viral Diseases Division, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia; the Division of Virology, Office of Biologics, National Center for Drugs and Biologics, U.S. Food and Drug Administration, and the Epidemiology and Biometry Section, Clinical and Epidemiological Studies Branch, Microbiology and Infectious Diseases Program, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland; the Biometry Section, Caries Prevention and Research Branch, National Institute of Dental Research; and the Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts